Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Vinci

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
HGG Advances|June 27, 2026
Pediatric High-Grade Gliomas and Cancer Predisposition Syndromes: A Retrospective StudySelene Cipri, Giada Del Baldo, Emanuele Agolini, et al.
Hepatology International|April 13, 2020
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Monica Monti, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Acta Neuropathologica|July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signallingFrancesca Nazio, Agnese Po, Luana Abballe, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.
Neuro-Oncology|July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapseStacey Richardson, Rebecca M Hill, Christopher Kui, et al.
The Journal of Clinical Investigation|September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma modelsSantiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Journal of Neuro-Oncology|November 29, 2018
Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Journal of Neuro-Oncology|November 18, 2018
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
HGG Advances|June 27, 2026
Pediatric High-Grade Gliomas and Cancer Predisposition Syndromes: A Retrospective StudySelene Cipri, Giada Del Baldo, Emanuele Agolini, et al.
Hepatology International|April 13, 2020
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Monica Monti, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Acta Neuropathologica|July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signallingFrancesca Nazio, Agnese Po, Luana Abballe, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.
Neuro-Oncology|July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapseStacey Richardson, Rebecca M Hill, Christopher Kui, et al.
The Journal of Clinical Investigation|September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma modelsSantiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Journal of Neuro-Oncology|November 29, 2018
Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Journal of Neuro-Oncology|November 18, 2018
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Pageof 9